CA2535463A1 - Octreotide-pamoate et son utilisation dans des formulations de peptides hydrosolubles a liberation prolongee - Google Patents

Octreotide-pamoate et son utilisation dans des formulations de peptides hydrosolubles a liberation prolongee Download PDF

Info

Publication number
CA2535463A1
CA2535463A1 CA002535463A CA2535463A CA2535463A1 CA 2535463 A1 CA2535463 A1 CA 2535463A1 CA 002535463 A CA002535463 A CA 002535463A CA 2535463 A CA2535463 A CA 2535463A CA 2535463 A1 CA2535463 A1 CA 2535463A1
Authority
CA
Canada
Prior art keywords
microparticles
polymer
octreotide
drug
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002535463A
Other languages
English (en)
Inventor
David Bodmer
Jones W. Fong
Thomas Kissel
Oskar Nagele
Hawkins V. Maulding
Jane E. Pearson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from CA002316052A external-priority patent/CA2316052C/fr
Publication of CA2535463A1 publication Critical patent/CA2535463A1/fr
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA002535463A 1989-07-07 1990-07-05 Octreotide-pamoate et son utilisation dans des formulations de peptides hydrosolubles a liberation prolongee Expired - Lifetime CA2535463A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US37702389A 1989-07-07 1989-07-07
US377,023 1989-07-07
US41134789A 1989-09-22 1989-09-22
US411,347 1989-09-22
CA002316052A CA2316052C (fr) 1989-07-07 1990-07-05 Formules de peptides hydrosolubles a liberation continue

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002316052A Division CA2316052C (fr) 1989-07-07 1990-07-05 Formules de peptides hydrosolubles a liberation continue

Publications (1)

Publication Number Publication Date
CA2535463A1 true CA2535463A1 (fr) 1991-01-08

Family

ID=36242603

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002535463A Expired - Lifetime CA2535463A1 (fr) 1989-07-07 1990-07-05 Octreotide-pamoate et son utilisation dans des formulations de peptides hydrosolubles a liberation prolongee

Country Status (1)

Country Link
CA (1) CA2535463A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150366973A1 (en) * 2007-06-15 2015-12-24 Camurus Ab Peptide slow-release formulations
US11672843B2 (en) 2012-05-25 2023-06-13 Camurus Ab Somatostatin receptor agonist formulations

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150366973A1 (en) * 2007-06-15 2015-12-24 Camurus Ab Peptide slow-release formulations
US11672843B2 (en) 2012-05-25 2023-06-13 Camurus Ab Somatostatin receptor agonist formulations

Similar Documents

Publication Publication Date Title
CA2020477C (fr) Formules de peptides hydrosolubles a liberation continue
US5876761A (en) Sustained release formulations of water soluble peptides
US5688530A (en) Sustained release formulations of water soluble peptides
WO2007071395A1 (fr) Formulation a liberation prolongee comprenant l'octreotide et deux copolymeres de polylactide-glycolide ou plus
WO2009095450A1 (fr) Préparation à libération soutenue comprenant de l'octréotide et trois polymères linéaires polylactide-co-glycolide
CA2316052C (fr) Formules de peptides hydrosolubles a liberation continue
CA2654113A1 (fr) Formulations a liberation prolongee d'inhibiteurs de l'aromatase
CA2535463A1 (fr) Octreotide-pamoate et son utilisation dans des formulations de peptides hydrosolubles a liberation prolongee
FI106926B (fi) Menetelmä pitkäaikaisesti vapautuvan koostumuksen muodostamiseksi
IL112286A (en) Process for the production of a microparticle and microparticle obtained thereby
NL195092C (nl) Preparaten van in water oplosbare peptiden met een langzame afgifte.
SA90110050B1 (ar) مستحضرات ممتدة المفعول لببتيدات تذوب في الماء

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry